HAYA Therapeutics develops precision RNA-guided therapeutics targeting long non-coding RNA for treating aggressive solid tumors and other diseases.

Airna is a biotech company that specializes in RNA editing therapeutics, aiming to target diseases inaccessible through other methods, with its first program focusing on treating the inherited genetic disease alpha-1 antitrypsin deficiency (AATD).

Constructive Bio transforms living cells into biofactories for creating new biomolecules, aiming to revolutionize drug manufacturing and discovery through synthetic genomics.

Vandria is a biotechnology company developing small molecule mitophagy inducers to treat age-related and chronic diseases.

H55 is a Swiss company that develops and commercializes electric and hybrid propulsion systems and battery technologies for the aviation industry.

Partillion Bioscience is a life science tools company that develops a single-cell analysis platform using its proprietary Nanovial technology for screening individual cells based on functional information.

Airna is a biotech company that specializes in RNA editing therapeutics, aiming to target diseases inaccessible through other methods, with its first program focusing on treating the inherited genetic disease alpha-1 antitrypsin deficiency (AATD).